Cause of death during upper tract urothelial carcinoma survivorship: A contemporary, population-based analysis

被引:1
作者
Peng, Fu-Sheng [1 ]
Wu, Wan-Ting [2 ]
Zhang, Lu [2 ]
Shen, Jia-Hua [3 ]
Yu, Dong-Dong [1 ]
Mao, Li-Qi [4 ]
机构
[1] Huzhou Univ, Dept Urol, Affiliated Cent Hosp, Huzhou Cent Hosp, Huzhou, Peoples R China
[2] Huzhou Univ, Major Clin Med, Huzhou, Peoples R China
[3] Huzhou Wu Xing Dist Med Insurance Management Serv, Dept Med Insurance Fund Supervis Sect, Huzhou, Peoples R China
[4] Huzhou Univ, Affiliated Hosp 1, Peoples Hosp Huzhou 1, Dept Gastroenterol, Huzhou, Peoples R China
关键词
cause of death; upper urinary tract carcinoma; standardized mortality ratios (SMRs); excess absolute risks (EARs); surveillance epidemiology and end results (SEER); TRANSITIONAL-CELL CARCINOMA; BLADDER-CANCER; SURVIVAL; URETER; PELVIS; RISK;
D O I
10.3389/fonc.2022.948289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundVery few studies have been published on the causes of death of upper tract urothelial carcinoma (UTUC). We sought to explore the mortality patterns of contemporary UTUC survivors. MethodsWe performed a retrospective cohort study involving patients with upper urinary tract carcinoma from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database (2000 and 2015). We used standardized mortality ratios (SMRs) to compare death rates among patients with UTUC in the general population and excess absolute risks (EARs) to quantify the disease-specific death burden. ResultsA total of 10,179 patients with UTUC, including 7,133 who died, were included in our study. In total, 302 (17.17%) patients with the localized disease died of UTUC; however, patients who died from other causes were 4.8 times more likely to die from UTUC (n = 1,457 [82.83%]). Cardiovascular disease was the most common non-cancer cause of death (n = 393 [22.34% of all deaths]); SMR, 1.22; 95% confidence intervals [CI], 1.1-1.35; EAR, 35.96). A total of 4,046 (69.99%) patients with regional stage died within their follow-up, 1,413 (34.92%) of whom died from UTUC and 1,082 (26.74%) of whom died from non-cancer causes. UTUC was the main cause of death (SMR, 242.48; 95% CI, 230-255.47; EAR, 542.47), followed by non-tumor causes (SMR, 1.18; 95% CI, 1.11-1.25; EAR, 63.74). Most patients (94.94%) with distant stage died within 3 years of initial diagnosis. Although UTUC was the leading cause of death (n = 721 [54.29%]), these patients also had a higher risk of death from non-cancer than the general population (SMR, 2.08; 95% CI, 1.67-2.56; EAR, 288.26). ConclusionsNon-UTUC deaths accounted for 82.48% of UTUC survivors among those with localized disease. Patients with regional/distant stages were most likely to die of UTUC; however, there is an increased risk of dying from non-cancer causes that cannot be ignored. These data provide the latest and most comprehensive assessment of the causes of death in patients with UTUC.
引用
收藏
页数:10
相关论文
共 23 条
[1]   Clinical and Prognostic Factors for Renal Parenchymal, Pelvis, and Ureter Cancers in SEER Registries: Collaborative Stage Data Collection System, Version 2 [J].
Altekruse, Sean F. ;
Dickie, Lois ;
Wu, Xiao-Cheng ;
Hsieh, Mei-Chin ;
Wu, Manxia ;
Lee, Richard ;
Delacroix, Scott, Jr. .
CANCER, 2014, 120 (23) :3826-3835
[2]   Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study [J].
Armenian, Saro H. ;
Xu, Lanfang ;
Ky, Bonnie ;
Sun, Canlan ;
Farol, Leonardo T. ;
Pal, Sumanta Kumar ;
Douglas, Pamela S. ;
Bhatia, Smita ;
Chao, Chun .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) :1122-+
[3]   Outcomes in stage I testicular seminoma: A population-based study of 9193 patients [J].
Beard, Clair J. ;
Travis, Lois B. ;
Chen, Ming-Hui ;
Arvold, Nils D. ;
Nguyen, Paul L. ;
Martin, Neil E. ;
Kuban, Deborah A. ;
Ng, Andrea K. ;
Hoffman, Karen E. .
CANCER, 2013, 119 (15) :2771-2777
[4]   Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016 [J].
Dores, Graca M. ;
Curtis, Rochelle E. ;
Dalal, Nicole H. ;
Linet, Martha S. ;
Morton, Lindsay M. .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (35) :4149-U19
[5]   Causes of Death After Colorectal Cancer Diagnosis: A Population-Based Study [J].
Feng, Yuqian ;
Jin, Huimin ;
Guo, Kaibo ;
Wasan, Harpreet S. ;
Ruan, Shanming ;
Chen, Cihui .
FRONTIERS IN ONCOLOGY, 2021, 11
[6]  
Howlader N., 2021, SEER Cancer Statistics Review, 1975-2018
[7]   Evaluating Overall Survival and Competing Risks of Death in Patients With Localized Renal Cell Carcinoma Using a Comprehensive Nomogram [J].
Kutikov, Alexander ;
Egleston, Brian L. ;
Wong, Yu-Ning ;
Uzzo, Robert G. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) :311-317
[8]   A Novel Nomogram Based on a Competing Risk Model Predicting Cardiovascular Death Risk in Patients With Chronic Kidney Disease [J].
Li, Ning ;
Zhang, Jingjing ;
Xu, Yumeng ;
Yu, Manshu ;
Zhou, Guowei ;
Zheng, Yawei ;
Zhou, Enchao ;
He, Weiming ;
Sun, Wei ;
Xu, Lingdong ;
Zhang, Lu .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
[9]   Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract [J].
Matsui, Y ;
Utsunomiya, N ;
Ichioka, K ;
Ueda, N ;
Yoshimura, K ;
Terai, A ;
Arai, Y .
UROLOGY, 2005, 65 (02) :279-283
[10]   Bladder cancer after managing upper urinary tract transitional cell carcinoma: risk factors and survival [J].
Milojevic, Bogomir ;
Djokic, Milan ;
Sipetic-Grujicic, Sandra ;
Milenkovic-Petronic, Dragica ;
Vuksanovic, Aleksandar ;
Dragicevic, Dejan ;
Bumbasirevic, Uros ;
Tulic, Cane .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2011, 43 (03) :729-735